Please download the dossier by clicking on the dossier button x
×

5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES

  • US 20190117636A1
  • Filed: 03/28/2017
  • Published: 04/25/2019
  • Est. Priority Date: 03/29/2016
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for reducing the rate of accumulation of amyloid plaques comprising administering an effective amount of a 5-HT2A serotonin receptor inverse agonist or antagonist, or a pharmaceutically acceptable salt thereof to a subject.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×